Validation Of Progression-Free Survival (Pfs) As Surrogate Endpoint In Randomised Trials Of Immune Checkpoint Inhibitors In Advanced Solid Cancers P. S. Kok,W-H. Yoon, I. Marschner,S. J. Lord,M. Friedlander, C. K. LeeANNALS OF ONCOLOGY（2019）引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
